125 related articles for article (PubMed ID: 3274336)
1. In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.
Tesi RJ; Hong J; Butt KM; Jaffe BM; McMillen MA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1382-4. PubMed ID: 3274336
[TBL] [Abstract][Full Text] [Related]
2. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
[No Abstract] [Full Text] [Related]
3. Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period.
Cofer BR; Tchervenkov JI; Alexander JW; Barnwell SC
Transplant Proc; 1991 Feb; 23(1 Pt 1):157-8. PubMed ID: 1990501
[No Abstract] [Full Text] [Related]
4. Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.
Harland RC; Halperin EC; Yamaguchi Y; Ruiz P; Scroggs MW; Sanfilippo F; Bollinger RR
Transplant Proc; 1989 Feb; 21(1 Pt 1):1118-9. PubMed ID: 2650071
[No Abstract] [Full Text] [Related]
5. Synergistic effect of UV-irradiated donor-specific transfusions with peritransplant cyclosporine on cardiac allograft survival in rats.
Oluwole S; Lau H; Reemtsma K; Hardy MA
Transplant Proc; 1987 Feb; 19(1 Pt 1):451-3. PubMed ID: 3274803
[No Abstract] [Full Text] [Related]
6. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
[No Abstract] [Full Text] [Related]
8. Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine.
Jiang H; Takahara S; Takano Y; Li D; Kyo M; Valdivia LA; Kokado Y; Ishibashi M; Sonoda T
Transplant Proc; 1991 Feb; 23(1 Pt 1):540-1. PubMed ID: 1703702
[No Abstract] [Full Text] [Related]
9. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
[No Abstract] [Full Text] [Related]
10. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effects of leflunomide in a cardiac allograft model.
Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
[No Abstract] [Full Text] [Related]
12. Survival of cardiac allograft in highly sensitized and nonsensitized rats treated with FK506.
Takahara S; Jiang H; Ishibashi M; Okuyama A; Sonoda T
J Clin Lab Immunol; 1991 Apr; 34(4):179-81. PubMed ID: 1726566
[TBL] [Abstract][Full Text] [Related]
13. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
[No Abstract] [Full Text] [Related]
14. Interaction between third-party blood transfusions and cyclosporine in rat heterotopic heart transplantation.
McKenzie FN; Duplan J; Campbell C; Menkis A; Stiller C; Keown P; Kostuk W
Transplant Proc; 1988 Dec; 20(6):1243-4. PubMed ID: 3059614
[No Abstract] [Full Text] [Related]
15. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.
Ochiai T; Nakajima K; Nagata M; Suzuki T; Asano T; Uematsu T; Goto T; Hori S; Kenmochi T; Nakagoori T
Transplant Proc; 1987 Feb; 19(1 Pt 2):1284-6. PubMed ID: 2484094
[No Abstract] [Full Text] [Related]
16. Cardiac allograft tolerance induction with limited immunosuppression.
Cohen DS; Fisher RA; Tarry WC; Tawes JW
J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
[No Abstract] [Full Text] [Related]
18. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
[No Abstract] [Full Text] [Related]
19. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
[No Abstract] [Full Text] [Related]
20. Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells.
Choti M; Lenrow D; Roza A; Markmann J; Naji A
Transplant Proc; 1989 Feb; 21(1 Pt 1):478-9. PubMed ID: 2565055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
